Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10882907 Multispecific antibodies that target HIV GP120 and CD3

Patent 10882907 was granted and assigned to Gilead Sciences on January, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+202 characters)
Article

Patent abstract

Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.

Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1088290700
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 22 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10882907
Edits on 9 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Feb, 2022
Edits made to:
Infobox (+13 properties)
‌

 US Patent 10882907 Multispecific antibodies that target HIV GP120 and CD3

Infobox
Is a
Patent
Patent
Patent applicant
Gilead Sciences
Gilead Sciences
Current assignee
Gilead Sciences
Gilead Sciences
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10882907
Date of patent
January 5, 2021
Patent application number
16014153
Date Filed
June 21, 2018
Patent citations
‌
US Patent 10087239 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
‌
US Patent 10184000 Optimized Fc variants and methods for their generation
‌
US Patent 10336818 Fc variants with altered binding to FcRn
‌
US Patent 10584176 Fc variants with increased affinity for FcγRIIc
Patent primary examiner
‌
Jeffrey S. Parkin

Find more entities like US Patent 10882907 Multispecific antibodies that target HIV GP120 and CD3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.